FDA Inspection
Barr Laboratories Inc.Barr Laboratories Inc. – FDA Inspection, Feb 28, 2018
Record Details
This FDA Inspection record concerns Barr Laboratories Inc., with an inspection on February 28, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · eec5beb6-d10d-4ca4-99c9-83f6c553cd38
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1050298
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
- Outcome
- Form 483 issued
Other FDA inspections of Barr Laboratories Inc.
12| Date | Classification | Office | Project area |
|---|---|---|---|
| May 9, 2025 | VAI | Baltimore District Office | Vaccine, Allergenic, and Live Biotherapeutic Products |
| November 4, 2022 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| November 9, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 8, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 14, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Barr Laboratories Inc.
- FDA Inspection 1253861 - 2025-05-09
- FDA Inspection 1191739 - 2022-11-04
- FDA Inspection 1072231 - 2018-11-09
- FDA Inspection 1056486 - 2018-06-08
- FDA Inspection 1032245 - 2017-04-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.